Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:ATCCode |
none (not yet assigned)
|
| gptkbp:CASNumber |
1449271-42-4
|
| gptkbp:clinicalTrialPhase |
Phase 2
|
| gptkbp:developedBy |
gptkb:Astellas_Pharma
|
| https://www.w3.org/2000/01/rdf-schema#label |
YM3014
|
| gptkbp:intendedUse |
treatment of psychiatric disorders
|
| gptkbp:mechanismOfAction |
selective orexin 1 receptor antagonist
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:status |
investigational
|
| gptkbp:UNII |
1Q1K6Q6Q1B
|
| gptkbp:bfsParent |
gptkb:Yamaha_YM2203
gptkb:YM2203 |
| gptkbp:bfsLayer |
7
|